Global Recombinant Protein Market Report and Forecast 2024-2032

Global Recombinant Protein Market Size

The global recombinant protein market was valued at USD 1.9 billion in 2023, driven by the increasing demand for effective drugs to treat chronic diseases across the globe. The market is expected to grow at a CAGR of 11.21% during the forecast period of 2024 and 2032, likely to attain a value of USD 5 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Recombinant Protein Market Outlook

• The market growth is expected to grow in value due to the increasing demand for effective and efficient drugs for improved treatment of patients. The development of such drugs has been sped up due to the creation of various effective recombinant protein-based vaccines created for COVID-19.

• The rising prevalence of chronic illness is likely to enhance the demand for recombinant protein therapies due to their effectiveness in treating such diseases. The market is expected to expand further with the growing number of cancer cases.

• With the rising demand for effective drugs for specific diseases, key players and government agencies are increasingly investing in the development of novel drugs, which is expected to propel the market development further.

Global Recombinant Protein Market Overview

Recombinant proteins are synthesized using recombinant DNA methods, where a new gene sequence is produced and the coded protein is inserted into host organism such as bacteria, yeast, or animal cells to produce the protein. It involves gene cloning and transformation. It enables selection, expression, purification and study of the protein. Recombinant proteins are vital in medicine (for instance, insulin and monoclonal antibodies), research, industry, and agriculture because their quality is standardized, the expression level can be easily scaled up and fine-tuned according to the needs. In addition, the production can be customized depending on the specific application. It offers advantages like purity and offers advantages like cost efficiency, making it ideal for mass production.

Global Recombinant Protein Market Growth Drivers

Increased Application in Disease Management

Diseases like cerebral apoplexy, multiple sclerosis, neutropenia, and thrombocytopenia are becoming more common, boosting the demand for recombinant proteins. Cancer is a highly common and fast-growing chronic disease among the major chronic diseases. The American Cancer Society (ACS) analysis from 2023 projected 1,958,310 and 609,820 deaths in United States, requiring effective and precise treatment alternatives to combat the condition. Recombinant proteins are also used in the treatments like such as chemotherapy, cell culture, western blot, animal cell culture, glycosylation, biotherapeutic products, and bioengineering, thereby, boosting the global market value.

Surge in Partnerships Between Leading Players to Meet Rising Recombinant Protein Market Demand

In January 2024, Nucleus Biologics, a top cell culture media provider, entered a deal with Core Biogenesis to distribute and manufacture affordable and sustainable recombinant proteins. Together, the two companies aim to work together and deliver better, cheaper reagents and media to the cell and gene therapy markets. As per the terms of agreement, Nucleus Biologics will act as a GMP manufacturer for Core Biogenesis’ recombinant proteins. Such partnerships are expected to shape the market landscape effectively, as it works to provide precise and affordable solutions to consumers.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Recombinant Protein Market Trends

Global Recombinant Protein Market Segmentation

Market Breakup by Product Type

• Growth Factor and Cytokines

• Hormone

• Enzyme

• Antibody

• Immune Checkpoint Proteins

• Recombinant Regulatory Proteins

• Others

Market Breakup by Application

• Therapeutic

• Research

• Biotechnology Industry

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Recombinant Protein Market Share

Hormones Lead the Market Based on Product Type

Based on product type, the market can be divided into growth factor and cytokines, hormones, enzymes, antibodies, immune checkpoint proteins, and recombinant regulatory proteins, among others. The hormones segment is likely to take lead, owing to its versatility, particularly in the areas of research and innovation, including the development of therapies for diseases including diabetes. Hormones are very essential in the body involved in treatment for various diseases. Moreover, ease of intake makes it a popular alternative amongst users, affecting the market dynamics significantly.

Biotechnology Industry is Anticipated to Have Largest Market Share Based on Application

Based on application, the market is divided into therapeutic, research, biotechnology Industry. Among these biotechnology industry is expected to hold a significant market share, as it widely applies recombinant proteins at the clinical stages of designing, testing, and manufacturing new drugs. Recombinant proteins are central to the development of biopharmaceuticals and translate research successes into production that is clinically scalable.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Recombinant Protein Market Analysis by Region

Various regions covered in the global market report include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Based on the regional analysis, North America is projected to hold largest market share in the forecast period, driven by increasing prevalence of diseases like cancer, diabetes, cardiovascular diseases, chronic respiratory diseases, among others. Growth in research and development activities between key market stakeholders and governments to meet the rising need for efficient medicine and treatment is also play a critical role in boosting market value.

The Asia Pacific region is likely to grow at a faster rate, owing to factors such as increasing healthcare expenditure, the growing biotechnology sector, and the upsurge in interest in recombinant protein therapies. For instance, in May 2023, Thermo Fisher Scientific Inc., and National Research and Innovation Agency (BRIN) entered the Memorandum of Understanding (MOU) with the aim of strengthening the Indonesian research and innovation systems and capacities. The partnership was aimed at helping and supporting country-level research and innovation institutions and their capacities towards improving scientific activity and the Indonesian economy. The collaboration can be viewed as a move towards enhancing the capacity of Indonesia to contribute and advance in the global realm of research and innovation.

Leading Players in the Global Recombinant Protein Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis along with strategic initiatives by the key players. The major companies in the market are as follows:

Abcam PLC

Founded in 1998, this company occupies a premier position in the market dealing in protein research tools. The specific areas of expertise crafted by the company include primary antibodies and secondary antibodies, proteins and peptides, knockout cell lines and lysates, and cell and tissue imaging reagents, among others.

Thermo Fisher Scientific, Inc.,

Known as one of the largest biotechnology research companies, it is based in Massachusetts, United States. The company operates in different sectors, which include analytical instruments, lab supply chain services and e-business solutions, general lab equipment and services, specialty diagnostics, life science records, pharma solutions, contract development, and manufacturing organization.

Bio-Techne Corp.

This United States based company is a provider of purified proteins and reagent solutions to customers in pharmaceuticals and other specialty markets. It is also involved in protein analysis solutions, like analyzing solutions services and produces antibodies, enzymes, proteins, cell culture reagents, and others.

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. is a leading global pharmaceutical firm with a functional base in Basel, Switzerland; the firm operates in recombinant proteins, among many others. It works in different therapeutic segments, which include oncology, immunology, and infectious disease.

Other companies in the market include Abbott, Merck KGaA, Bio-Rad Laboratories, Inc., GeneTex, Inc, Lonza Group SA, PerkinElmer Inc., Sino Biological Inc., TAKARA HOLDINGS INC., Tosoh Corporation, XENOTECH AI Pvt Ltd., and NEW ENGLAND BIOLABS, INC.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Recombinant Protein Market Report Snapshots

Recombinant Protein Market Size

Recombinant Protein Market Growth

Recombinant Protein Market Trends

Recombinant Protein Market Share

Recombinant Protein Regional Analysis

Recombinant Protein Companies

Key Questions Answered in the Recombinant Protein Market Report

• What was the global recombinant protein market value in 2023?
• What is the global recombinant protein market forecast outlook for 2024-2032?
• What are the regional markets covered in the EMR report?
• What is the market segmentation based on product types?
• What is the market breakup based on application?
• What are the major factors aiding the global recombinant protein market demand? 
• What are the market's major drivers, opportunities, and restraints? 
• Which regional market is expected to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• What are the major global recombinant protein market trends?
• How does the rise in the geriatric population impact the market size?
• Who are the key players involved in the recombinant protein market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
• What are the key challenges faced by biotechnology companies in producing recombinant proteins?
• What factors are driving the growth of the recombinant protein market in North America?
• What technological advancements are driving innovation in the recombinant protein market?
• How are global regulatory frameworks affecting the production and distribution of recombinant proteins?